|
|
Received: 02 February 2021
|
|
|
|
|
[1] 藏君. 丁苯酞注射液联合依达拉奉治疗急性脑梗死的临床效果[J].中国医药,2019,14(5):83-86. [2] 龚红英,李通.丁苯酞治疗急性脑梗死的临床研究[J].现代药物与临床,2017,32(1):51-54. [3] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682. [4] Caesar R R,Carlile M C,Gentilello L M,et al.Usefulness of the Abbreviated Injury Score and the Injury Severity Score in Comparison to the Glasgow Coma Scale in Predicting Outcome After Traumatic Brain Injury[J].J Trauma,2007,62(4):946-950. [5] 吕春雷. 联合应用丁苯酞与奥扎格雷钠治疗急性重症脑梗死患者的效果研究[J].中国实用医药,2019,14(25):72-74. [6] 严秋凤,谢宁.丁苯酞胶囊对急性脑梗死患者血清SOD、NSE的影响[J].中南药学,2017,15(4):535-537. [7] 王艳茹,周国亮,张月婵,等.丁苯酞联合奥扎格雷钠治疗急性重症脑梗死患者临床效果[J].中国医药导报,2018,15(15):123-126. [8] 殷艳玲,王雁飞,马娟,等.艾司西酞普兰联合奥扎格雷钠治疗急性脑梗死合并焦虑抑郁障碍的临床研究[J].河北医学,2018,24(11):150-154. |
[1] |
. [J]. journal1, 2022, 42(2): 82-83. |
[2] |
. [J]. journal1, 2022, 42(2): 130-131. |
[3] |
. [J]. journal1, 2022, 42(2): 123-125. |
[4] |
. [J]. journal1, 2022, 42(2): 126-127. |
[5] |
. [J]. journal1, 2022, 42(2): 137-138. |
[6] |
Lan Shaoyong, Lin Dong, Su Binru. Clinical Study of Low-Dose Urokinase in the Treatment of Acute Mild Cerebral Infarction[J]. journal1, 2022, 42(1): 1-4. |
|
|
|